iAnthus- 10X Growth Series

Executive Summary

iAnthus is a multi-state operator with a compelling valuation, top-quality management team and a unique share structure that favors common shareholders. Capital 10X analysts have put together the most comprehensive free guide to this undervalued stock available anywhere.

Here is just a sample of the valuable information contained in the 50+ page report:

    • U.S. cannabis market potential (Market size estimates by 2025 and 2035)
    • Why iAnthus offers 100-400% upside
    • Upcoming catalysts that will move the stock in 2019
    • A state by state asset breakdown
    • See why iAnthus trades at a 35% discount to peers


UPSIDE CASE: $17.00 – $35.00/SH

iAnthus 10X Growth Series Report



In the interest of full disclosure, Capital 10X employees’ own shares in iAnthus. More information on the profiled company can be found by reviewing the public filings of iAnthus Capital Holdings Inc. on SEDAR at www.sedar.com. Writers at Capital10X.com are not certified financial analysts or licensed in the securities industry in any manner and the content of this report may not be complete, accurate or current. iAnthus is a consulting client of Capital 10X and though the information contained herein is believed to be the subjective opinion of the author, this business relationship could create a conflict of interest.

The opinions provided in this article are those of the author and do not constitute investment advice. Readers should assume that the author and/or employees of Capital 10X hold positions in the company or companies mentioned in the article. For more information, please see our Content Disclaimer.

Capital 10X gets down to the real money business, actionable financial insights for traders and investors. We analyze company earnings, interview management teams and help teach the fundamentals of financial analysis and options trading. Our mission is to hunt for genuine 10 baggers.

Leave a Reply

Notify of